Fully Automated Cassette‐Based Synthesis of 2‐Deoxy‐2‐[ 18 F]Fluorocellobiose Using Trasis AllInOne Module
Journal of Labelled Compounds and Radiopharmaceuticals · 2024
DOI: 10.1002/jlcr.4116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2024. Verfasst von Falguni Basuli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Cellobiose. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Due to the continuous rise in global incidence and severity of invasive fungal infections (IFIs), particularly among immunocompromised and immunodeficient patients, there is an urgent demand for swift and accurate fungal pathogen diagnosis. Therefore, the need for fungal‐specific positron emission tomography (PET) imaging agents that can detect the infection in the early stages is increasing. Cellobiose, a disaccharide, is readily metabolized by fungal pathogens such as Aspergillus species. Recently, our group reported fluorine‐18 labeled cellobiose, 2‐deoxy‐2‐[ 18 F]fluorocellobiose ([ 18 F]FCB), for specific imaging of Aspergillus infection. The positive imaging findings with very low background signal on delayed imaging make this ligand a promising fungal‐specific imaging ligand. Inspired by this result, the decision was made to automate the radiolabeling procedure for better reproducibility and to facilitate clinical translation. A Trasis AllInOne (Trasis AIO) automated module was used for this purpose. The reagent vials contain commercially available 2‐deoxy‐2‐[ 18 F]fluoroglucose ([ 18 F]FDG), glucose‐1‐phosphate, and enzyme (cellobiose phosphorylase). A Sep‐Pak cartridge was used to purify the tracer. The overall radiochemical yield was 50%–70% ( n = 6, decay corrected) in 75‐min synthesis time with a radiochemical purity of > 98%. This is a highly reliable protocol to produce current good manufacturing practice (cGMP)–compliant [ 18 F]FCB for clinical PET imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry and Synthesis Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockville, Maryland, USA.
- Center for Infectious Disease Imaging, Radiology and Imaging Sciences, Clinical Center (CC), National Institutes of Health (NIH), Bethesda, Maryland, USA.
ORCID-Profile: Falguni Basuli
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Basuli, F., Shi, J., Shah, S., Lai, J., Hammoud, D. A., & Swenson, R. E. (2024). Fully Automated Cassette‐Based Synthesis of 2‐Deoxy‐2‐[ 18 F]Fluorocellobiose Using Trasis AllInOne Module. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4116
Vancouver
Basuli F, Shi J, Shah S, Lai J, Hammoud DA, Swenson RE. Fully Automated Cassette‐Based Synthesis of 2‐Deoxy‐2‐[ 18 F]Fluorocellobiose Using Trasis AllInOne Module. Journal of Labelled Compounds and Radiopharmaceuticals. 2024. doi:10.1002/jlcr.4116
BibTeX
@article{Basuli2024,
author = {Basuli, Falguni and Shi, Jianfeng and Shah, Swati and Lai, Jianhao and Hammoud, Dima A and Swenson, Rolf E},
title = {Fully Automated Cassette‐Based Synthesis of 2‐Deoxy‐2‐[ 18 F]Fluorocellobiose Using Trasis AllInOne Module},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2024},
doi = {10.1002/jlcr.4116}
}
EUVIMED